DZ Bank’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-5,190
Closed -$545K 1116
2018
Q1
$545K Buy
+5,190
New +$619K ﹤0.01% 779

Other funds holding VBIV

DZ Bank's VBIV Position: Q2 2018 in Review

DZ Bank sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q2 2018, closing a stake of 5,190 shares — an estimated $545K sold.

DZ Bank first reported a position in VBIV in Q1 2018 and held it in 1 quarter. The position peaked at $545K in Q1 2018. 48 funds tracked by Wall St. Rank hold VBIV as of Q2 2018.

  • DZ Bank reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q2 2018 after selling out during the quarter.
  • DZ Bank sold 5,190 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q2 2018, an estimated $545K.
  • DZ Bank first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q1 2018 and held it in 1 quarter.
  • DZ Bank's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $545K in Q1 2018.
  • 48 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q2 2018.

Based on DZ Bank's 13F filing for Q2 2018, filed 14 Aug 2018.